Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Neuromodulation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global neuromodulation market reached a value of US$ 6.05 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 11.84 Billion by 2027, exhibiting a CAGR of 11.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Neuromodulation is a medical technique used for the modulation and alteration of nerve activities by delivering electrical or pharmaceutical agents directly to the targeted area. It consists of tiny electrodes that generate electrical stimulation with the help of pulse generators to supplement neurological activities in the patients. The electrodes are generally placed in the nerves, brain, or spinal cord, whereas pulse generators are implanted within the skin. Neuromodulation is widely used to treat depression, chronic pain, epilepsy, tremor, migraine, failed back syndrome, Parkinson's disease, and gastroparesis. It includes the vagal nerve, deep brain, transcranial magnetic, and electrical stimulation. It assists in monitoring nerve activity, alleviating symptoms, and normalizing activity levels in the brain.

Neuromodulation Market Trends:

The rising geriatric population and the increasing prevalence of Alzheimer's and Parkinson's diseases across the globe are key factors driving the market growth. Neuromodulation is widely used to treat overactive bladder, low movement, rigidity, tremor, walking problems, neurodegenerative, and neurological disorders. Moreover, technological innovations, such as the introduction of lithium-ion (Li-ion) batteries that provide high energy density, rechargeability, and enhanced cycling temperature, are providing a considerable boost to the market growth. Additionally, the widespread utilization of spinal cord stimulation (SCS) in various medical problems, such as complex regional pain syndrome, neuropathy, nerve damage, failed-back surgery syndrome, and arachnoiditis, is positively impacting the market growth. Apart from this, the increasing usage of deep brain stimulation (DBS) that delivers low bipolar or monopolar electric impulses and is used in the treatment of depression and obsessive-compulsive disorders (OCD) is creating a positive outlook for the market. Other factors, such as extensive research and development (R&D) activities and significant growth in the healthcare industry, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global neuromodulation market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on technology, biomaterial and application.

Breakup by Technology:

  • Internal Neuromodulation
    • Spinal Cord Stimulation (SCS)
    • Deep Brain Stimulation (DBS)
    • Vagus Nerve Stimulation (VNS)
    • Sacral Nerve Stimulation (SNS)
    • Gastric Electrical Stimulation (GES)
  • External Neuromodulation
    • Transcutaneous Electrical Nerve Stimulation (TENS)
    • Transcranial Magnetic Stimulation (TMS)
    • Others
       

Breakup by Biomaterial:

  • Metallic Biomaterials
  • Polymeric Biomaterials
  • Ceramic Biomaterials
     

Breakup by Application:

  • Parkinson's Disease
  • Epilepsy
  • Depression
  • Dystonia
  • Pain Management
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bioventus Inc., Boston Scientific Corporation, Helius Medical Technologies, Integer Holdings Corporation, LivaNova PLC, Medtronic plc, MicroTransponder Inc., Neuronetics, NeuroPace Inc., NeuroSigma Inc., Nevro Corp.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Technology, Biomaterial, Application, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Bioventus Inc., Boston Scientific Corporation, Helius Medical Technologies, Integer Holdings Corporation, LivaNova PLC, Medtronic plc, MicroTransponder Inc., Neuronetics, NeuroPace Inc., NeuroSigma Inc., Nevro Corp.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global neuromodulation market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global neuromodulation market?
  • What are the key regional markets?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the biomaterial?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global neuromodulation market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Neuromodulation Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Technology
    6.1    Internal Neuromodulation
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 Spinal Cord Stimulation (SCS)
           6.1.2.2 Deep Brain Stimulation (DBS)
           6.1.2.3 Vagus Nerve Stimulation (VNS)
           6.1.2.4 Sacral Nerve Stimulation (SNS)
           6.1.2.5 Gastric Electrical Stimulation (GES)
        6.1.3 Market Forecast
    6.2    External Neuromodulation
        6.2.1 Market Trends
        6.2.2 Key Segments
           6.2.2.1 Transcutaneous Electrical Nerve Stimulation (TENS)
           6.2.2.2 Transcranial Magnetic Stimulation (TMS)
           6.2.2.3 Others
        6.2.3 Market Forecast
7    Market Breakup by Biomaterial
    7.1    Metallic Biomaterials
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Polymeric Biomaterials
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Ceramic Biomaterials
        7.3.1 Market Trends
        7.3.2 Market Forecast
8    Market Breakup by Application
    8.1    Parkinson's Disease
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Epilepsy
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Depression
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Dystonia
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Pain Management
        8.5.1 Market Trends
        8.5.2 Market Forecast
    8.6    Others
        8.6.1 Market Trends
        8.6.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Abbott Laboratories
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Bioventus Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    Boston Scientific Corporation
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Helius Medical Technologies
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
        14.3.5    Integer Holdings Corporation
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
        14.3.6    LivaNova PLC
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
        14.3.7    Medtronic plc
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    MicroTransponder Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
        14.3.9    Neuronetics
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
        14.3.10    NeuroPace Inc.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
        14.3.11    NeuroSigma Inc.
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
        14.3.12    Nevro Corp.
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio
           14.3.12.3 Financials

List of Figures

Figure 1: Global: Neuromodulation Market: Major Drivers and Challenges
Figure 2: Global: Neuromodulation Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Neuromodulation Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Neuromodulation Market: Breakup by Technology (in %), 2021
Figure 5: Global: Neuromodulation Market: Breakup by Biomaterial (in %), 2021
Figure 6: Global: Neuromodulation Market: Breakup by Application (in %), 2021
Figure 7: Global: Neuromodulation Market: Breakup by Region (in %), 2021
Figure 8: Global: Neuromodulation (Internal Neuromodulation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Neuromodulation (Internal Neuromodulation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Neuromodulation (External Neuromodulation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Neuromodulation (External Neuromodulation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Neuromodulation (Metallic Biomaterials) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Neuromodulation (Metallic Biomaterials) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Neuromodulation (Polymeric Biomaterials) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Neuromodulation (Polymeric Biomaterials) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Neuromodulation (Ceramic Biomaterials) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Neuromodulation (Ceramic Biomaterials) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Neuromodulation (Parkinson's Disease) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Neuromodulation (Parkinson's Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Neuromodulation (Epilepsy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Neuromodulation (Epilepsy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Neuromodulation (Depression) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Neuromodulation (Depression) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Neuromodulation (Dystonia) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Neuromodulation (Dystonia) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Neuromodulation (Pain Management) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Neuromodulation (Pain Management) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Neuromodulation (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Neuromodulation (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: North America: Neuromodulation Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: North America: Neuromodulation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: United States: Neuromodulation Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: United States: Neuromodulation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Canada: Neuromodulation Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Canada: Neuromodulation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Asia-Pacific: Neuromodulation Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Asia-Pacific: Neuromodulation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: China: Neuromodulation Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: China: Neuromodulation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Japan: Neuromodulation Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Japan: Neuromodulation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: India: Neuromodulation Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: India: Neuromodulation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: South Korea: Neuromodulation Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: South Korea: Neuromodulation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Australia: Neuromodulation Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Australia: Neuromodulation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Indonesia: Neuromodulation Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Indonesia: Neuromodulation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Others: Neuromodulation Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Others: Neuromodulation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Europe: Neuromodulation Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Europe: Neuromodulation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Germany: Neuromodulation Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Germany: Neuromodulation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: France: Neuromodulation Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: France: Neuromodulation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: United Kingdom: Neuromodulation Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: United Kingdom: Neuromodulation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Italy: Neuromodulation Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Italy: Neuromodulation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Spain: Neuromodulation Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Spain: Neuromodulation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Russia: Neuromodulation Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Russia: Neuromodulation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Others: Neuromodulation Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Others: Neuromodulation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Latin America: Neuromodulation Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Latin America: Neuromodulation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Brazil: Neuromodulation Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Brazil: Neuromodulation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Mexico: Neuromodulation Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Mexico: Neuromodulation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Others: Neuromodulation Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Others: Neuromodulation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Middle East and Africa: Neuromodulation Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Middle East and Africa: Neuromodulation Market: Breakup by Country (in %), 2021
Figure 78: Middle East and Africa: Neuromodulation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Global: Neuromodulation Industry: SWOT Analysis
Figure 80: Global: Neuromodulation Industry: Value Chain Analysis
Figure 81: Global: Neuromodulation Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Neuromodulation Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Neuromodulation Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 3: Global: Neuromodulation Market Forecast: Breakup by Biomaterial (in Million US$), 2022-2027
Table 4: Global: Neuromodulation Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Neuromodulation Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Neuromodulation Market: Competitive Structure
Table 7: Global: Neuromodulation Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links